Xeal Pharma
United Kingdom
About Ultra Jean-G (aka. Super-G Citra)
UJGSativa HybridUltra Jean-G is a cross between Ultra Sour x Lemon Margy and the result, as tokers might expect, is something full of gassy, lemony, and herbal aromas, with a lovely pine complement to this high-octane bouquet.
Proprietary Strain
Combined, these two heavy hitters yield a sativa-dominant bud, with THC sky-rocketing to the super range of 23-29% for all you weary tokers.
Description provided by PEI Cannabis Corp.
Information provided could come from a third-party source, and may not accurately reflect characteristics of the medication we're associating it with - we primarily provide these descriptions for those interested in strain lineage and history, which could also be inaccurate. Any information which could be taken as medical advice should be strictly disregarded. Please consult your doctor regarding the suitability of medications for your condition(s).
About 4C Labs Ltd.
We are a vertically-integrated medical cannabis cultivator and digital healthcare provider. A holistic solution and platform that makes medical cannabis more accessible.
Moving forward with a value-driven strategy. The 4C name was conceived from a value-first approach for our patients and doctors – which is why Care, Commitment, Choice and Change are more than just concepts to us; they are the very foundation on which our company was built.
This is reflected in the team that we have spent the last several years assembling that spans compliance, cultivation, technology, engineering and healthcare. A team with the sole focus of revolutionising medical cannabis for both patients and doctors in the UK.
UK patients deserve access to medicines that have been tested, certified and grown organically using proven cannabis genetics. With a deep understanding of plant genetics and innovative dosing strategies, 4C Labs delivers custom tailored solutions to address patients’ specific needs.
4C Labs’ cultivation strategy is spear-headed by a Canadian Master Grower with 25+ years experience supplying sought after products to compassion centres that serve the cancer community and others who suffer from chronic illnesses.
We are primed to scale with the market and have considerably lower set-up costs when compared to many other cannabis companies.
Our state of the art data analytics platform (under development) is set up to deliver insights to our R&D Team that will lead to innovative solutions to common global human health issues.
4clabs.co
Further National Health-Service Information on